Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma injections can effectively treat male pattern hair loss, improving hair density and quality with high patient satisfaction.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Hairless protein affects hair follicle structure by regulating the Dlx3 gene.

MED1 is essential for normal hair growth and maintaining hair follicle stem cells.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Understanding how acne develops in different diseases could lead to new treatments.

Terminalia bellirica extracts effectively promote hair regrowth and treat androgenetic alopecia.

Surgery can be a safe and effective option for infertile women with PCOS who don't respond to medication and want to get pregnant.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Increased FGFR2b signaling, influenced by androgens, plays a role in causing acne.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Hair follicles could be used to noninvasively monitor our body's internal clock and help identify risks for related diseases.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Disrupted stem cell signals in hairpoor mice cause hair loss.

New regenerative therapies show promise for treating hair loss.

Finasteride harms Daphnia magna's reproduction, growth, and metabolism.

PRP therapy for hair loss is safe but its effectiveness is doubtful.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

DEEPLY ROOTED® supplement seems to effectively improve hair growth and quality in women with no side effects.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.